4 Comments
User's avatar
steve's avatar

"Fiesty', ever so; thank you Dr. Nash for with your comment! For, to those in attendance at the AUA Conference in 2017 Howard HAD to "steal" time, and, who'd never admit to reading Howard's blog, NO CHANGE but same can not be said of most present that day. Started near 6 decades ago, "Hands off!", "Hell no we won' go!" In fairness, who is willing to admit he/she saw it comin'?

To Dr. Shee, grateful to have you on board. Despite one clear message in this blog or webinars PSAV/PSADT, like other tools, ".....should not be sole criterion for intervention.", what is the state of current research into either, if at all?

Expand full comment
Harley Myler's avatar

Good stuff!

Expand full comment
Howard Wolinsky's avatar

Guy,

Patients are often left hanging on the best thing to do. For every MD, there seems to be an equal and opposite MD arguing for on e side or another.

My former urologist gave a speech recently to a major urology group where he questioned the value of PSA velocity. https://howardwolinsky.substack.com/p/top-doc-gives-prostate-cancer-state

So I asked Dr. Shee, our new columnist, to explain PSA velocity.

One thing there seems to be a consensus on; PSA density. The urologists tend to think PSA density (PSAD) is more useful; than PSA alone.

Dr. Leapman on PSAD: https://howardwolinsky.substack.com/p/yale-urologic-oncologist-michael?utm_source=publication-search

Also:

https://howardwolinsky.substack.com/p/harvard-researchers-confirm-value?utm_source=publication-search

Expand full comment
Guylaine's avatar

Thank you, even though not conclusive, good information and education.

Expand full comment